gastrointestinal%20stromal%20tumor
GASTROINTESTINAL STROMAL TUMOR
Gastrointestinal stromal tumors are morphologically spindle cell, epithelioid, or occasionally pleomorphic mesenchymal tumors of the gastrointestinal tract.
Signs and symptoms of gastrointestinal tumor include presence of abdominal mass (which may be an incidental finding in endoscopy), gastrointestinal bleeding, hemoperitoneum, anemia and gastrointestinal perforation.

Surgical Intervention

  • Complete surgical excision is the standard treatment of localized gastrointestinal stromal tumor (GIST)
    • Initial management of small GISTs <2 cm w/ high-risk endoscopic ultrasound (EUS) features
  • Wide local resection w/ 1- to 2-cm margin is done for most tumors
  • Tumors located in the colon may require hemicolectomy while tumors located in the rectum & anus will require abdominoperineal resection of the anus & rectum
  • Surgery may be warranted in unresectable or metastatic GIST if there is limited disease progression unresponsive to Imatinib or a locally advanced previously unresectable tumor which had a good response to Imatinib preoperatively

Preoperative Assessment

  • Computed tomography (CT) scan of the chest & abdomen should be done on all patients
    • Angiography performed if necessary (eg major vessels occluded by the tumor)
  • If large tumors are considered on the right or left upper quadrant of the abdomen, endocrine clearance should be done to exclude adrenal tumors
  • Alpha-fetoprotein (AFP) & beta-human chorionic gonadotropin (Β-hCG) levels should be determined in male patients w/ centrally placed tumors to exclude teratomas
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, Yesterday
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
6 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
6 days ago
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.